Joseph Brueggen

Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues

Éric Biron, Jayanta Chatterjee, Oded Ovadia et al. · Angewandte Chemie International Edition · 2008 · 372 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

Heidi A. Lane, Jeanette M. Wood, Paul M.J. McSheehy et al. · Clinical Cancer Research · 2009 · 251 citations · Full text

Medicine, Oncology, Pharmacology +17

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone

Simon Wöhrle, Olivier Bonny, Noémie Beluch et al. · Journal of Bone and Mineral Research · 2011 · 147 citations

Medicine, Endocrinology, Nephrology +17

The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis

Georg Martiny‐Baron, Philipp Holzer, Éric Billy et al. · Angiogenesis · 2010 · 126 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo

Terence O’Reilly, Markus Wartmann, Joseph Brueggen et al. · Cancer Chemotherapy and Pharmacology · 2008 · 71 citations

Medicine, Oncology, Pharmacology +11